Crossmark

Immunotherapy of cancer in the era of checkpoint inhibitor

Crossref DOI link: https://doi.org/10.1007/s10585-021-10132-9

Published Online: 2021-12-08

Published Print: 2022-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mehmi, Inderjit https://orcid.org/0000-0002-2253-2206
Hamid, Omid
License Information

Text and Data Mining valid from 2021-12-08

Version of Record valid from 2021-12-08
More Information

Article History

Received: 27 January 2021

Accepted: 2 November 2021

First Online: 8 December 2021